SIMILAR PATTERNS OF AMINO ACIDS FOR 1XWF_B_ADNB433_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ccr | CYTOCHROME C (Oryza sativa) |
PF00034(Cytochrom_C) | 5 | THR A 71ASP A 60HIS A 26LEU A 40LEU A 43 | NoneHEM A 112 (-3.6A)HEM A 112 (-3.2A)NoneNone | 1.15A | 1xwfB-1ccrA:undetectable | 1xwfB-1ccrA:14.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1coz | PROTEIN(GLYCEROL-3-PHOSPHATECYTIDYLYLTRANSFERASE) (Bacillussubtilis) |
PF01467(CTP_transf_like) | 5 | LEU A 21THR A 6LEU A 111GLY A 92PHE A 10 | NoneNoneNoneCTP A 130 (-3.3A)CTP A 130 (-4.3A) | 1.14A | 1xwfB-1cozA:3.3 | 1xwfB-1cozA:15.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 53GLU A 58ASP A 234LEU A 389LEU A 392GLY A 397MET A 403PHE A 407 | NoneADN A 502 (-3.6A)ADN A 502 (-2.8A)NAD A 501 ( 3.8A)ADN A 502 ( 4.9A)ADN A 502 ( 3.7A)ADN A 502 (-3.6A)None | 1.03A | 1xwfB-1v8bA:50.1 | 1xwfB-1v8bA:52.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 9 | LEU A 53HIS A 54GLU A 58ASP A 134ASP A 234LEU A 392GLY A 397MET A 403PHE A 407 | NoneADN A 502 (-4.1A)ADN A 502 (-3.6A)ADN A 502 (-3.1A)ADN A 502 (-2.8A)ADN A 502 ( 4.9A)ADN A 502 ( 3.7A)ADN A 502 (-3.6A)None | 0.99A | 1xwfB-1v8bA:50.1 | 1xwfB-1v8bA:52.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 9 | LEU A 53HIS A 54THR A 56GLU A 58ASP A 134ASP A 234GLY A 397MET A 403PHE A 407 | NoneADN A 502 (-4.1A)ADN A 502 (-3.0A)ADN A 502 (-3.6A)ADN A 502 (-3.1A)ADN A 502 (-2.8A)ADN A 502 ( 3.7A)ADN A 502 (-3.6A)None | 0.81A | 1xwfB-1v8bA:50.1 | 1xwfB-1v8bA:52.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 53THR A 56GLU A 58ASP A 234LEU A 389GLY A 397MET A 403PHE A 407 | NoneADN A 502 (-3.0A)ADN A 502 (-3.6A)ADN A 502 (-2.8A)NAD A 501 ( 3.8A)ADN A 502 ( 3.7A)ADN A 502 (-3.6A)None | 1.00A | 1xwfB-1v8bA:50.1 | 1xwfB-1v8bA:52.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wix | HOOK HOMOLOG 1 (Mus musculus) |
PF05622(HOOK) | 5 | LEU A 74GLU A 112LEU A 18LEU A 117GLY A 114 | None | 1.19A | 1xwfB-1wixA:undetectable | 1xwfB-1wixA:17.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xnf | LIPOPROTEIN NLPI (Escherichiacoli) |
PF07719(TPR_2)PF13181(TPR_8) | 5 | THR A 107ASP A 120LEU A 148LEU A 140GLY A 137 | None | 1.06A | 1xwfB-1xnfA:undetectable | 1xwfB-1xnfA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1y23 | HISTIDINE TRIADPROTEIN (Bacillussubtilis) |
PF01230(HIT) | 5 | LEU A 43HIS A 104ASP A 33GLY A 95PHE A 9 | None | 1.16A | 1xwfB-1y23A:undetectable | 1xwfB-1y23A:16.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2c27 | MYCOTHIOL SYNTHASE (Mycobacteriumtuberculosis) |
PF00583(Acetyltransf_1) | 5 | LEU A 127THR A 121LEU A 65LEU A 80GLY A 92 | NoneACO A1313 (-3.6A)NoneACO A1313 (-4.2A)ACO A1313 (-3.4A) | 1.04A | 1xwfB-2c27A:undetectable | 1xwfB-2c27A:22.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2y8u | CHITIN DEACETYLASE (Aspergillusnidulans) |
PF01522(Polysacc_deac_1) | 5 | LEU A 73HIS A 97THR A 98ASP A 48LEU A 139 | None CO A1239 ( 3.3A)None CO A1239 ( 2.4A)PO4 A1238 ( 4.8A) | 1.05A | 1xwfB-2y8uA:undetectable | 1xwfB-2y8uA:19.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3aja | PUTATIVEUNCHARACTERIZEDPROTEIN (Mycolicibacteriumsmegmatis) |
PF01083(Cutinase) | 5 | LEU A 206THR A 261ASP A 209ASP A 184GLY A 253 | None | 1.20A | 1xwfB-3ajaA:5.2 | 1xwfB-3ajaA:22.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 252LEU A 407LEU A 410GLY A 415MET A 421 | ADN A 500 (-2.7A)NAD A 550 (-4.2A)ADN A 500 ( 4.8A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A) | 1.08A | 1xwfB-3ce6A:50.4 | 1xwfB-3ce6A:54.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 363LEU A 407LEU A 410GLY A 415MET A 421 | ADN A 500 ( 3.7A)NAD A 550 (-4.2A)ADN A 500 ( 4.8A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A) | 0.78A | 1xwfB-3ce6A:50.4 | 1xwfB-3ce6A:54.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 363LEU A 410GLY A 415MET A 421PHE A 425 | ADN A 500 ( 3.7A)ADN A 500 ( 4.8A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-4.8A) | 0.75A | 1xwfB-3ce6A:50.4 | 1xwfB-3ce6A:54.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 68HIS A 69ASP A 156ASP A 252LEU A 407PHE A 425 | NoneADN A 500 (-4.0A)ADN A 500 (-2.9A)ADN A 500 (-2.7A)NAD A 550 (-4.2A)ADN A 500 (-4.8A) | 1.38A | 1xwfB-3ce6A:50.4 | 1xwfB-3ce6A:54.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 68HIS A 69ASP A 156ASP A 252LEU A 410GLY A 415MET A 421PHE A 425 | NoneADN A 500 (-4.0A)ADN A 500 (-2.9A)ADN A 500 (-2.7A)ADN A 500 ( 4.8A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-4.8A) | 0.99A | 1xwfB-3ce6A:50.4 | 1xwfB-3ce6A:54.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 68HIS A 69THR A 71ASP A 156ASP A 252GLY A 415MET A 421PHE A 425 | NoneADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-2.9A)ADN A 500 (-2.7A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-4.8A) | 0.80A | 1xwfB-3ce6A:50.4 | 1xwfB-3ce6A:54.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | THR A 71HIS A 363GLY A 415MET A 421PHE A 425 | ADN A 500 (-2.8A)ADN A 500 ( 3.7A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-4.8A) | 0.80A | 1xwfB-3ce6A:50.4 | 1xwfB-3ce6A:54.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 52HIS A 300LEU A 346GLY A 351MET A 357PHE A 361 | ADN A 438 (-4.0A)ADN A 438 ( 4.0A)ADN A 438 ( 4.8A)ADN A 438 ( 3.8A)ADN A 438 (-3.7A)None | 0.98A | 1xwfB-3g1uA:54.2 | 1xwfB-3g1uA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 52THR A 54HIS A 300GLY A 351MET A 357PHE A 361 | ADN A 438 (-4.0A)ADN A 438 (-2.8A)ADN A 438 ( 4.0A)ADN A 438 ( 3.8A)ADN A 438 (-3.7A)None | 0.90A | 1xwfB-3g1uA:54.2 | 1xwfB-3g1uA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 300LEU A 343LEU A 346GLY A 351MET A 357 | ADN A 438 ( 4.0A)NAD A 439 ( 4.0A)ADN A 438 ( 4.8A)ADN A 438 ( 3.8A)ADN A 438 (-3.7A) | 0.76A | 1xwfB-3g1uA:54.2 | 1xwfB-3g1uA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LEU A 51HIS A 52ASP A 130LEU A 343PHE A 361 | NoneADN A 438 (-4.0A)ADN A 438 (-4.1A)NAD A 439 ( 4.0A)None | 1.20A | 1xwfB-3g1uA:54.2 | 1xwfB-3g1uA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 51HIS A 52ASP A 130LEU A 346GLY A 351MET A 357PHE A 361 | NoneADN A 438 (-4.0A)ADN A 438 (-4.1A)ADN A 438 ( 4.8A)ADN A 438 ( 3.8A)ADN A 438 (-3.7A)None | 0.92A | 1xwfB-3g1uA:54.2 | 1xwfB-3g1uA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 51HIS A 52THR A 54ASP A 130GLY A 351MET A 357PHE A 361 | NoneADN A 438 (-4.0A)ADN A 438 (-2.8A)ADN A 438 (-4.1A)ADN A 438 ( 3.8A)ADN A 438 (-3.7A)None | 0.68A | 1xwfB-3g1uA:54.2 | 1xwfB-3g1uA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 233LEU A 385LEU A 388GLY A 393MET A 399 | RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A) | 1.03A | 1xwfB-3glqA:52.9 | 1xwfB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 344LEU A 385LEU A 388GLY A 393MET A 399 | RAB A 602 ( 3.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A) | 0.69A | 1xwfB-3glqA:52.9 | 1xwfB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 344LEU A 388GLY A 393MET A 399PHE A 403 | RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.68A | 1xwfB-3glqA:52.9 | 1xwfB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 61HIS A 62ASP A 139ASP A 233LEU A 385PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)None | 1.28A | 1xwfB-3glqA:52.9 | 1xwfB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 61HIS A 62ASP A 139ASP A 233LEU A 388GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.96A | 1xwfB-3glqA:52.9 | 1xwfB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 61HIS A 62THR A 64ASP A 139ASP A 233GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.79A | 1xwfB-3glqA:52.9 | 1xwfB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | THR A 64HIS A 344GLY A 393MET A 399PHE A 403 | RAB A 602 (-2.7A)RAB A 602 ( 3.5A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.73A | 1xwfB-3glqA:52.9 | 1xwfB-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | ASP A 189LEU A 343LEU A 346GLY A 351MET A 357PHE A 361 | NAD A 438 ( 4.4A)NAD A 438 (-4.0A)ADN A 439 ( 4.7A)ADN A 439 (-3.5A)ADN A 439 ( 3.7A)None | 1.03A | 1xwfB-3h9uA:56.6 | 1xwfB-3h9uA:71.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 52HIS A 300LEU A 346GLY A 351MET A 357PHE A 361 | ADN A 439 ( 4.7A)NoneADN A 439 ( 4.7A)ADN A 439 (-3.5A)ADN A 439 ( 3.7A)None | 1.03A | 1xwfB-3h9uA:56.6 | 1xwfB-3h9uA:71.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 52THR A 54HIS A 300GLY A 351MET A 357PHE A 361 | ADN A 439 ( 4.7A)ADN A 439 (-2.7A)NoneADN A 439 (-3.5A)ADN A 439 ( 3.7A)None | 0.95A | 1xwfB-3h9uA:56.6 | 1xwfB-3h9uA:71.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 300LEU A 343LEU A 346GLY A 351MET A 357PHE A 361 | NoneNAD A 438 (-4.0A)ADN A 439 ( 4.7A)ADN A 439 (-3.5A)ADN A 439 ( 3.7A)None | 0.72A | 1xwfB-3h9uA:56.6 | 1xwfB-3h9uA:71.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 51HIS A 52ASP A 130ASP A 189LEU A 346GLY A 351MET A 357PHE A 361 | NoneADN A 439 ( 4.7A)NoneNAD A 438 ( 4.4A)ADN A 439 ( 4.7A)ADN A 439 (-3.5A)ADN A 439 ( 3.7A)None | 0.94A | 1xwfB-3h9uA:56.6 | 1xwfB-3h9uA:71.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 51HIS A 52THR A 54ASP A 130ASP A 189GLY A 351MET A 357PHE A 361 | NoneADN A 439 ( 4.7A)ADN A 439 (-2.7A)NoneNAD A 438 ( 4.4A)ADN A 439 (-3.5A)ADN A 439 ( 3.7A)None | 0.79A | 1xwfB-3h9uA:56.6 | 1xwfB-3h9uA:71.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hp7 | HEMOLYSIN, PUTATIVE (Streptococcusthermophilus) |
PF01479(S4)PF01728(FtsJ) | 5 | LEU A 122THR A 93GLU A 52LEU A 70GLY A 66 | None | 1.04A | 1xwfB-3hp7A:5.1 | 1xwfB-3hp7A:22.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 226LEU A 378LEU A 381GLY A 386MET A 392 | ADN A 500 ( 2.6A)NAD A 550 (-4.3A)ADN A 500 ( 4.8A)ADN A 500 (-3.7A)ADN A 500 (-3.7A) | 0.96A | 1xwfB-3n58A:52.7 | 1xwfB-3n58A:58.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 55HIS A 337LEU A 381GLY A 386MET A 392PHE A 396 | ADN A 500 (-4.0A)ADN A 500 ( 3.6A)ADN A 500 ( 4.8A)ADN A 500 (-3.7A)ADN A 500 (-3.7A)None | 0.98A | 1xwfB-3n58A:52.7 | 1xwfB-3n58A:58.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 55THR A 57HIS A 337GLY A 386MET A 392PHE A 396 | ADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-3.7A)None | 0.92A | 1xwfB-3n58A:52.7 | 1xwfB-3n58A:58.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 337LEU A 378LEU A 381GLY A 386MET A 392 | ADN A 500 ( 3.6A)NAD A 550 (-4.3A)ADN A 500 ( 4.8A)ADN A 500 (-3.7A)ADN A 500 (-3.7A) | 0.67A | 1xwfB-3n58A:52.7 | 1xwfB-3n58A:58.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 54HIS A 55ASP A 132ASP A 226LEU A 378PHE A 396 | NoneADN A 500 (-4.0A)ADN A 500 (-3.3A)ADN A 500 ( 2.6A)NAD A 550 (-4.3A)None | 1.31A | 1xwfB-3n58A:52.7 | 1xwfB-3n58A:58.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 54HIS A 55ASP A 132ASP A 226LEU A 381GLY A 386MET A 392PHE A 396 | NoneADN A 500 (-4.0A)ADN A 500 (-3.3A)ADN A 500 ( 2.6A)ADN A 500 ( 4.8A)ADN A 500 (-3.7A)ADN A 500 (-3.7A)None | 0.93A | 1xwfB-3n58A:52.7 | 1xwfB-3n58A:58.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 54HIS A 55THR A 57ASP A 132ASP A 226GLY A 386MET A 392PHE A 396 | NoneADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-3.3A)ADN A 500 ( 2.6A)ADN A 500 (-3.7A)ADN A 500 (-3.7A)None | 0.76A | 1xwfB-3n58A:52.7 | 1xwfB-3n58A:58.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 62ASP A 139ASP A 239LEU A 398GLY A 403MET A 409PHE A 413 | ADE A 506 (-4.6A)NoneNAD A 501 ( 4.5A)ADE A 506 ( 4.7A)ADE A 506 ( 3.6A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.97A | 1xwfB-3oneA:49.7 | 1xwfB-3oneA:57.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 62THR A 64ASP A 139ASP A 239GLY A 403MET A 409PHE A 413 | ADE A 506 (-4.6A)ADE A 506 (-2.8A)NoneNAD A 501 ( 4.5A)ADE A 506 ( 3.6A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.80A | 1xwfB-3oneA:49.7 | 1xwfB-3oneA:57.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 61ASP A 239LEU A 395LEU A 398GLY A 403MET A 409 | NoneNAD A 501 ( 4.5A)NAD A 501 (-4.2A)ADE A 506 ( 4.7A)ADE A 506 ( 3.6A)ADE A 506 (-3.8A) | 1.06A | 1xwfB-3oneA:49.7 | 1xwfB-3oneA:57.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 61HIS A 62ASP A 239LEU A 398GLY A 403MET A 409PHE A 413 | NoneADE A 506 (-4.6A)NAD A 501 ( 4.5A)ADE A 506 ( 4.7A)ADE A 506 ( 3.6A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.96A | 1xwfB-3oneA:49.7 | 1xwfB-3oneA:57.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 61HIS A 62THR A 64ASP A 239GLY A 403MET A 409PHE A 413 | NoneADE A 506 (-4.6A)ADE A 506 (-2.8A)NAD A 501 ( 4.5A)ADE A 506 ( 3.6A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.83A | 1xwfB-3oneA:49.7 | 1xwfB-3oneA:57.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 61HIS A 350LEU A 395LEU A 398GLY A 403MET A 409 | NoneNoneNAD A 501 (-4.2A)ADE A 506 ( 4.7A)ADE A 506 ( 3.6A)ADE A 506 (-3.8A) | 0.85A | 1xwfB-3oneA:49.7 | 1xwfB-3oneA:57.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 61HIS A 350LEU A 398GLY A 403MET A 409PHE A 413 | NoneNoneADE A 506 ( 4.7A)ADE A 506 ( 3.6A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.87A | 1xwfB-3oneA:49.7 | 1xwfB-3oneA:57.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 61THR A 64HIS A 350GLY A 403MET A 409PHE A 413 | NoneADE A 506 (-2.8A)NoneADE A 506 ( 3.6A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.92A | 1xwfB-3oneA:49.7 | 1xwfB-3oneA:57.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4l8l | 3-DEHYDROQUINATEDEHYDRATASE 1 (Pseudomonasaeruginosa) |
PF01220(DHquinase_II) | 5 | HIS A 8GLU A 36LEU A 15LEU A 28GLY A 29 | None | 1.08A | 1xwfB-4l8lA:5.0 | 1xwfB-4l8lA:15.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 342LEU A 383LEU A 386GLY A 391MET A 397PHE A 401 | ADN A 501 ( 3.7A)NAD A 503 ( 3.9A)ADN A 501 ( 4.7A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.70A | 1xwfB-4lvcA:52.2 | 1xwfB-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 57ASP A 231LEU A 383LEU A 386GLY A 391PHE A 401 | NoneADN A 501 (-3.1A)NAD A 503 ( 3.9A)ADN A 501 ( 4.7A)ADN A 501 (-3.6A)ADN A 501 (-4.8A) | 1.09A | 1xwfB-4lvcA:52.2 | 1xwfB-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 57HIS A 58ASP A 135ASP A 231LEU A 386GLY A 391PHE A 401 | NoneADN A 501 (-4.0A)ADN A 501 (-3.0A)ADN A 501 (-3.1A)ADN A 501 ( 4.7A)ADN A 501 (-3.6A)ADN A 501 (-4.8A) | 0.98A | 1xwfB-4lvcA:52.2 | 1xwfB-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 57HIS A 58ASP A 135LEU A 386GLY A 391MET A 397PHE A 401 | NoneADN A 501 (-4.0A)ADN A 501 (-3.0A)ADN A 501 ( 4.7A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.76A | 1xwfB-4lvcA:52.2 | 1xwfB-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 57HIS A 58THR A 60ASP A 135ASP A 231GLY A 391PHE A 401 | NoneADN A 501 (-4.0A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-3.1A)ADN A 501 (-3.6A)ADN A 501 (-4.8A) | 0.85A | 1xwfB-4lvcA:52.2 | 1xwfB-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 57HIS A 58THR A 60ASP A 135GLY A 391MET A 397PHE A 401 | NoneADN A 501 (-4.0A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.53A | 1xwfB-4lvcA:52.2 | 1xwfB-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 57LEU A 383LEU A 386GLY A 391MET A 397PHE A 401 | NoneNAD A 503 ( 3.9A)ADN A 501 ( 4.7A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.80A | 1xwfB-4lvcA:52.2 | 1xwfB-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 57THR A 60ASP A 231LEU A 383GLY A 391PHE A 401 | NoneADN A 501 (-2.8A)ADN A 501 (-3.1A)NAD A 503 ( 3.9A)ADN A 501 (-3.6A)ADN A 501 (-4.8A) | 1.10A | 1xwfB-4lvcA:52.2 | 1xwfB-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 57THR A 60LEU A 383GLY A 391MET A 397PHE A 401 | NoneADN A 501 (-2.8A)NAD A 503 ( 3.9A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.74A | 1xwfB-4lvcA:52.2 | 1xwfB-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | THR A 60HIS A 342LEU A 383GLY A 391MET A 397PHE A 401 | ADN A 501 (-2.8A)ADN A 501 ( 3.7A)NAD A 503 ( 3.9A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.83A | 1xwfB-4lvcA:52.2 | 1xwfB-4lvcA:58.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oj5 | TAILSPIKE PROTEIN (Escherichiavirus CBA120) |
no annotation | 5 | LEU A 667THR A 695LEU A 672GLY A 674PHE A 683 | None | 1.02A | 1xwfB-4oj5A:undetectable | 1xwfB-4oj5A:20.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4uy6 | HISTIDINE-SPECIFICMETHYLTRANSFERASEEGTD (Mycolicibacteriumsmegmatis) |
PF10017(Methyltransf_33) | 5 | LEU A 167THR A 163ASP A 141LEU A 85GLY A 86 | NoneSAH A 801 ( 3.7A)SAH A 801 (-3.7A)NoneSAH A 801 (-3.0A) | 1.17A | 1xwfB-4uy6A:4.4 | 1xwfB-4uy6A:22.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lki | TCDA1 (Photorhabdusluminescens) |
PF03538(VRP1) | 5 | LEU A1613THR A1607GLU A1634LEU A1766GLY A1762 | None | 1.20A | 1xwfB-5lkiA:undetectable | 1xwfB-5lkiA:10.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | LEU A 52HIS A 53THR A 55GLU A 57ASP A 137ASP A 245LEU A 404GLY A 409MET A 415PHE A 419 | NoneSAH A 502 (-4.0A)SAH A 502 (-2.7A)SAH A 502 (-3.7A)SAH A 502 (-3.4A)SAH A 502 (-2.8A)SAH A 502 ( 4.7A)SAH A 502 ( 3.7A)SAH A 502 (-3.6A)SAH A 502 (-4.8A) | 0.93A | 1xwfB-5utuA:48.5 | 1xwfB-5utuA:48.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 9 | LEU A 52THR A 55GLU A 57ASP A 245LEU A 401LEU A 404GLY A 409MET A 415PHE A 419 | NoneSAH A 502 (-2.7A)SAH A 502 (-3.7A)SAH A 502 (-2.8A)NAD A 501 (-4.1A)SAH A 502 ( 4.7A)SAH A 502 ( 3.7A)SAH A 502 (-3.6A)SAH A 502 (-4.8A) | 1.01A | 1xwfB-5utuA:48.5 | 1xwfB-5utuA:48.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 58ASP A 231LEU A 386LEU A 389GLY A 394MET A 400PHE A 404 | NoneADN A 502 (-2.8A)NAD A 501 (-3.9A)ADN A 502 ( 4.7A)ADN A 502 (-3.7A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 1.00A | 1xwfB-5v96A:51.6 | 1xwfB-5v96A:57.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 58HIS A 59ASP A 136ASP A 231LEU A 389GLY A 394MET A 400PHE A 404 | NoneADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)ADN A 502 ( 4.7A)ADN A 502 (-3.7A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 0.95A | 1xwfB-5v96A:51.6 | 1xwfB-5v96A:57.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 9 | LEU A 58HIS A 59THR A 61GLU A 63ASP A 136ASP A 231GLY A 394MET A 400PHE A 404 | NoneADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-3.6A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)ADN A 502 (-3.7A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 0.83A | 1xwfB-5v96A:51.6 | 1xwfB-5v96A:57.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 58THR A 61GLU A 63ASP A 231LEU A 386GLY A 394MET A 400PHE A 404 | NoneADN A 502 (-2.9A)ADN A 502 (-3.6A)ADN A 502 (-2.8A)NAD A 501 (-3.9A)ADN A 502 (-3.7A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 0.99A | 1xwfB-5v96A:51.6 | 1xwfB-5v96A:57.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | GLU A 59ASP A 131ASP A 190GLY A 352MET A 358PHE A 362 | 9W4 A 502 (-3.8A)NoneNAD A 501 (-4.1A)9W4 A 502 ( 3.9A)9W4 A 502 (-3.6A)None | 0.80A | 1xwfB-5w4bA:58.7 | 1xwfB-5w4bA:96.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | GLU A 59ASP A 190LEU A 344LEU A 347GLY A 352MET A 358PHE A 362 | 9W4 A 502 (-3.8A)NAD A 501 (-4.1A)NAD A 501 (-4.0A)9W4 A 502 (-4.1A)9W4 A 502 ( 3.9A)9W4 A 502 (-3.6A)None | 0.64A | 1xwfB-5w4bA:58.7 | 1xwfB-5w4bA:96.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LEU A 54HIS A 55ASP A 131ASP A 190LEU A 347 | None9W4 A 502 (-3.7A)NoneNAD A 501 (-4.1A)9W4 A 502 (-4.1A) | 1.17A | 1xwfB-5w4bA:58.7 | 1xwfB-5w4bA:96.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 54HIS A 55THR A 57GLU A 59ASP A 131ASP A 190MET A 358PHE A 362 | None9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)9W4 A 502 (-3.8A)NoneNAD A 501 (-4.1A)9W4 A 502 (-3.6A)None | 0.59A | 1xwfB-5w4bA:58.7 | 1xwfB-5w4bA:96.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xgw | ISOASPARTYLDIPEPTIDASE (Colwelliapsychrerythraea) |
no annotation | 5 | HIS A 203ASP A 256HIS A 234LEU A 106GLY A 105 | NoneNone ZN A 402 (-3.3A)NoneNone | 1.19A | 1xwfB-5xgwA:2.4 | 1xwfB-5xgwA:12.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5yy3 | - (-) |
no annotation | 5 | HIS A 346ASP A 322HIS A 180LEU A 350GLY A 351 | None | 1.14A | 1xwfB-5yy3A:undetectable | 1xwfB-5yy3A:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 195LEU A 349LEU A 352GLY A 357MET A 363 | ADN A 501 (-2.7A)NAD A 500 ( 4.3A)ADN A 501 ( 4.8A)ADN A 501 (-3.6A)ADN A 501 (-3.7A) | 1.05A | 1xwfB-6aphA:57.4 | 1xwfB-6aphA:66.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 58HIS A 306LEU A 352GLY A 357MET A 363PHE A 367 | ADN A 501 (-3.9A)ADN A 501 ( 3.7A)ADN A 501 ( 4.8A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)None | 0.98A | 1xwfB-6aphA:57.4 | 1xwfB-6aphA:66.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 58THR A 60HIS A 306GLY A 357MET A 363PHE A 367 | ADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 ( 3.7A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)None | 0.89A | 1xwfB-6aphA:57.4 | 1xwfB-6aphA:66.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 306LEU A 349LEU A 352GLY A 357MET A 363 | ADN A 501 ( 3.7A)NAD A 500 ( 4.3A)ADN A 501 ( 4.8A)ADN A 501 (-3.6A)ADN A 501 (-3.7A) | 0.78A | 1xwfB-6aphA:57.4 | 1xwfB-6aphA:66.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 57HIS A 58ASP A 136ASP A 195LEU A 349PHE A 367 | NoneADN A 501 (-3.9A)ADN A 501 (-3.0A)ADN A 501 (-2.7A)NAD A 500 ( 4.3A)None | 1.33A | 1xwfB-6aphA:57.4 | 1xwfB-6aphA:66.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 57HIS A 58ASP A 136ASP A 195LEU A 352GLY A 357MET A 363PHE A 367 | NoneADN A 501 (-3.9A)ADN A 501 (-3.0A)ADN A 501 (-2.7A)ADN A 501 ( 4.8A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)None | 0.95A | 1xwfB-6aphA:57.4 | 1xwfB-6aphA:66.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 57HIS A 58THR A 60ASP A 136ASP A 195GLY A 357MET A 363PHE A 367 | NoneADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-2.7A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)None | 0.79A | 1xwfB-6aphA:57.4 | 1xwfB-6aphA:66.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 6 | ASP B 198LEU B 373LEU B 376GLY B 381MET B 387PHE B 391 | ADN B 502 (-2.7A)NAD B 501 ( 3.9A)ADN B 502 ( 4.8A)ADN B 502 ( 3.7A)ADN B 502 (-3.7A)ADN B 502 (-4.9A) | 0.99A | 1xwfB-6f3mB:51.4 | 1xwfB-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 7 | HIS B 61ASP B 139ASP B 198LEU B 376GLY B 381MET B 387PHE B 391 | ADN B 502 ( 4.0A) ZN B 505 ( 2.5A)ADN B 502 (-2.7A)ADN B 502 ( 4.8A)ADN B 502 ( 3.7A)ADN B 502 (-3.7A)ADN B 502 (-4.9A) | 1.02A | 1xwfB-6f3mB:51.4 | 1xwfB-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 7 | HIS B 61THR B 63ASP B 139ASP B 198GLY B 381MET B 387PHE B 391 | ADN B 502 ( 4.0A)ADN B 502 (-2.8A) ZN B 505 ( 2.5A)ADN B 502 (-2.7A)ADN B 502 ( 3.7A)ADN B 502 (-3.7A)ADN B 502 (-4.9A) | 0.86A | 1xwfB-6f3mB:51.4 | 1xwfB-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 6 | HIS B 323LEU B 373LEU B 376GLY B 381MET B 387PHE B 391 | ZN B 505 (-3.2A)NAD B 501 ( 3.9A)ADN B 502 ( 4.8A)ADN B 502 ( 3.7A)ADN B 502 (-3.7A)ADN B 502 (-4.9A) | 0.73A | 1xwfB-6f3mB:51.4 | 1xwfB-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 5 | THR B 63HIS B 323GLY B 381MET B 387PHE B 391 | ADN B 502 (-2.8A) ZN B 505 (-3.2A)ADN B 502 ( 3.7A)ADN B 502 (-3.7A)ADN B 502 (-4.9A) | 0.76A | 1xwfB-6f3mB:51.4 | 1xwfB-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 6 | ASP A 193LEU A 347LEU A 350GLY A 355MET A 361PHE A 365 | ADN A 501 (-2.7A)NAD A 502 (-3.9A)ADN A 501 ( 4.7A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 0.96A | 1xwfB-6gbnA:57.5 | 1xwfB-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 6 | HIS A 56HIS A 304LEU A 350GLY A 355MET A 361PHE A 365 | ADN A 501 (-3.9A)ADN A 501 ( 3.6A)ADN A 501 ( 4.7A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 0.96A | 1xwfB-6gbnA:57.5 | 1xwfB-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 6 | HIS A 56THR A 58HIS A 304GLY A 355MET A 361PHE A 365 | ADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 ( 3.6A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 0.86A | 1xwfB-6gbnA:57.5 | 1xwfB-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 6 | HIS A 304LEU A 347LEU A 350GLY A 355MET A 361PHE A 365 | ADN A 501 ( 3.6A)NAD A 502 (-3.9A)ADN A 501 ( 4.7A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 0.71A | 1xwfB-6gbnA:57.5 | 1xwfB-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 8 | LEU A 55HIS A 56ASP A 134ASP A 193LEU A 350GLY A 355MET A 361PHE A 365 | NoneADN A 501 (-3.9A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)ADN A 501 ( 4.7A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 0.94A | 1xwfB-6gbnA:57.5 | 1xwfB-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 8 | LEU A 55HIS A 56THR A 58ASP A 134ASP A 193GLY A 355MET A 361PHE A 365 | NoneADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 0.76A | 1xwfB-6gbnA:57.5 | 1xwfB-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 6 | THR A 58ASP A 193LEU A 347GLY A 355MET A 361PHE A 365 | ADN A 501 (-2.8A)ADN A 501 (-2.7A)NAD A 502 (-3.9A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 0.96A | 1xwfB-6gbnA:57.5 | 1xwfB-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 6 | THR A 58HIS A 304LEU A 347GLY A 355MET A 361PHE A 365 | ADN A 501 (-2.8A)ADN A 501 ( 3.6A)NAD A 502 (-3.9A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 0.76A | 1xwfB-6gbnA:57.5 | 1xwfB-6gbnA:undetectable |